Perioperative dexamethasone in high-grade gliomas: the short-term benefits and long-term harms

Overview of attention for article published in Frontiers in oncology, December 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 3 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 49,684 followers.

RT @FrontOncology: New research: Perioperative dexamethasone in high-grade gliomas: the short-term benefits and long-term harms: Dexamethas…

29 Jan 2024

Reply Repost Favourite

Starting in the 1960s, brain cancer (glioma/glioblastoma) patients have been given dexamethasone without any evidence. We summarized the disadvantages of perioperative dexamethasone & endorsed future studies of DEX in brain cancers: https://t.co/39XY3b

04 Jan 2024

Reply Repost Favourite

RT @HWC_NL: Perioperative #dexamethasone in high-grade gliomas: the short-term benefits and long-term harms 👉https://t.co/PSpre9uB35 https…

18 Dec 2023

Reply Repost Favourite

RT @HWC_NL: Perioperative #dexamethasone in high-grade gliomas: the short-term benefits and long-term harms 👉https://t.co/PSpre9uB35 https…

18 Dec 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.